LENZ
LENZ Therapeutics Inc
3.80$
-9.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | 50.0% | – | 0.4% | 1.0% | 33.1% | 62.4% | 5.1% | 9.9% | |
| – | – | – | – | – | 50.0% | – | 99.6% | 99.0% | 66.9% | 37.6% | 94.9% | 90.1% | |
| – | – | – | – | – | 8,890.9% | – | 181.2% | 30.3% | 0.0% | 0.0% | 0.0% | 17.7% | |
| – | – | – | – | – | 14,177.3% | – | 255.9% | 220.8% | 2,495.8% | 2,365.1% | 717.8% | 705.8% | |
| – | – | – | – | – | 23,068.2% | – | 436.8% | 250.1% | 2,489.0% | 2,359.2% | 717.8% | 721.8% | |
| – | – | – | – | – | -23,068.2% | – | -337.1% | -151.1% | -2,422.1% | -2,321.7% | -622.9% | -631.7% | |
| – | – | – | – | – | -19,168.2% | – | -288.2% | -133.6% | -2,260.3% | -2,182.4% | -581.8% | -586.7% | |
| – | – | – | – | – | 1.5% | – | 10.0% | – | 0.1% | – | 0.1% | – | |
| – | – | – | – | – | -19,169.7% | – | -298.2% | -133.6% | -2,260.5% | -2,182.4% | -581.8% | -586.7% | |
| – | – | – | – | – | -19,130.3% | – | -287.9% | -132.6% | -2,253.6% | -2,176.6% | -579.7% | -584.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.